MDCL - Medicine Man Technologies, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
3.0200
-0.0900 (-2.89%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close3.1100
Open3.1100
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range2.9500 - 3.2400
52 Week Range1.0600 - 4.1700
Volume117,258
Avg. Volume175,312
Market Cap84.515M
Beta (3Y Monthly)1.45
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga2 days ago

    Former Albertsons CEO Ups His Medicine Man Tech Investment To $21M

    Medicine Man Technologies Inc (OTC: MDCL) announced that Dye Capital & Company is increasing its investment in the company from $14 million to $21 million. Justin Dye, Dye Capital Management Partner, is stepping up to serve as Medicine Man Technologies' Chairman of the Board. Dye was a leader in Albertsons Companies as it expanded its transactions to over $40 billion.

  • Benzinga20 days ago

    Medicine Man Technologies Appoints Lee Dayton As Chief Administrative Officer

    Medicine Man Technologies Inc (OTC: MDCL ) said Monday it appointed Albertsons Companies veteran Lee Dayton as its new Chief Administrative Officer. As Medicine Man Technologies' Chief Administrative Officer, ...

  • Benzingalast month

    Medicine Man Technologies Makes Third M&A Deal Of The Month, Plans to Acquire Colombia's Green Equity

    The vertically integrated company said Wednesday that it entered into a binding term sheet with the Colombian company Green Equity S.A.S. to acquire 100% of its assets. Medicine Man will pay $5.4 million for the company. If approved, the deal will consist of $450,000 in cash as well as 1,292,427 shares of Medicine Man common stock at $3.83 a share.

  • MarketWatchlast month

    Medicine Man Technologies to sell up to $14 million of stock to PE firm Dye Capital

    Medicine Man Technologies Inc. said Thursday it has entered a share sale agreement with private-equity firm Dye Capital & Co. for up to $14 million. The Denver, Colorado-based company will use the funds to finance growth and pending acquisitions, that include research and phytopharmaceuticals company Medicine Man Denver, Los Sueños Farms and cannabis products maker Mesa Organics. Two members of Dye Capital's board, Justin Dye and Leo Rivera, will join the Medicine Man board and Dye, who is managing partner, will become chairman. Dye Capital specializes in investments in the cannabis sector. Before founding Dye Capital, Justin Dye was part of the private-equity consortium that acquired supermarket chain Albertsons Companies. Medicine Man shares were not active premarket, but like many players in the new and speculative cannabis sector, have enjoyed outsize gains this year, rising 204% in 2019 to date, while the S&P 500 has gained 13%.

  • Benzinga2 months ago

    Medicine Man Technologies Makes 2 Cannabis Acquisitions In Colorado

    Medicine Man Technologies, Inc. (OTC: MDCL ) announced it will acquire Colorado-based cannabis farm, Los Sueños Farms, LLC, and cannabis dispensary Mesa Organics Ltd. These acquisitions will increase Medicine ...

  • Benzinga3 months ago

    National Brands, Blue Sky Startups Address Investors At Cannabis Capital Conference

    More than 40 international companies applied to address the assembled investors and industry experts at the Benzinga Cannabis Capital Conference, from major industry players to rapidly growing startups looking to scale in new markets. Targeting the side-effects and complications of pharmaceutical injury treatment, Copeland Biosciences produces CBD and THC topical formulations developed to provide targeted pain management and injury treatment. Founder and CEO Dr. Glenn Copeland said he experienced these side effects firsthand in his career as a sports medicine doctor.

  • Benzinga5 months ago

    KushCo, DionyMed And More Investor Presentations From The Cannabis Capital Conference

    The 2019 Benzinga Cannabis Capital Conference in Miami Beach included investor presentations from KushCo, Medicine Man and other major companies in the space. California-based Kushco, which began as a packaging company, is primarily focused on being as much of a business-to-business company as possible, Christoffersen said.

  • Market Exclusive6 months ago

    Medicine Man Acquiring MedPharm To Strengthen Cannabis Prospects

    Medicine Man Technologies Inc. (OTCMKTS:MDCL) has moved to strengthen its prospects in the Cannabis sector with the acquisition of MedPharm Holdings. The company has signed binding term sheets and conditions that pave the way for it to complete the acquisition of the cannabis research and product company. The transaction is slated for completion in the […] The post Medicine Man Acquiring MedPharm To Strengthen Cannabis Prospects appeared first on Market Exclusive.

  • Benzinga7 months ago

    How Medicine Man Tech's Brett Roper Changed The Cannabis Industry For The Better—And Why He Will Be Missed

    My eyes filled with tears as I read the news about Brett Roper, CEO of Medicine Man Technologies Inc (OTC: MDCL), passing away. With nothing left to do but grieve, I felt the need to pay this man -- a pioneer in the cannabis industry -- some due tribute. "I have known Brett for several years and admired him for always asking the right questions," he said.

  • Market Exclusive8 months ago

    Cannabis Stock News Daily Roundup December 3

    The global legal cannabis market is projected to hit $146.4 billion by end of 2025, according to research by Grand View Research. The legal cannabis industry is gaining traction worldwide due to high demand among consumers for recreational and medical products. Recreational cannabis spending is projected to hit $35 Billion mark, while medical cannabis spending […] The post Cannabis Stock News Daily Roundup December 3 appeared first on Market Exclusive.

  • Benzinga11 months ago

    Marijuana Is 'The Wrong Industry To Invest Blindly In,' Companies Must Stand Out To Succeed

    The cannabis industry's growing competitive landscape means companies must stand out in some way to succeed. At a Benzinga Cannabis Capital Conference panel hosted by Grant Thornton's Shaila Mehta, Cresco Labs CEO Charlie Bachtell said one of his company's keys to success is focusing on states with limited licenses that are more regulated than others. To succeed in a state with more government scrutiny, a marijuana company needs to make sure all aspects of their business are top quality to gain full trust and cooperation, Bachtell said.

  • This 32-year-old multimillionaire has been called the 'Steve Jobs of cannabis'
    CNBC Videos4 months ago

    This 32-year-old multimillionaire has been called the 'Steve Jobs of cannabis'

    Joshua Haupt is a 32-year-old marijuana multimillionaire who has been likened to the "Steve Jobs of cannabis." The Denver, Colorado resident grew up gardening and started growing cannabis in high school in order to treat his epilepsy. He credits his green thumb with developing growing methods that yield three times as much cannabis as the average grower. Haupt turned his growing methods into a $500 guidebook and a nutrient line that he sold to Medicine Man Technologies for 7 million shares.